Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Capital One (COF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Capital One (COF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Capital One (COF) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives

Community Financial System (CBU) Earnings Expected to Grow: Should You Buy?
Community Financial System (CBU) Earnings Expected to Grow: Should You Buy?

The market expects Community Financial System (CBU) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known

Badger Meter (BMI) Reports Next Week: Wall Street Expects Earnings Growth
Badger Meter (BMI) Reports Next Week: Wall Street Expects Earnings Growth

Badger Meter (BMI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives

Canadian National (CNI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Canadian National (CNI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Canadian National (CNI) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus

Analysts Estimate Baker Hughes (BKR) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Baker Hughes (BKR) to Report a Decline in Earnings: What to Look Out for

The market expects Baker Hughes (BKR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook

Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Coca-Cola (KO) to Report a Decline in Earnings: What to Look Out for

The market expects Coca-Cola (KO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is

Earnings Preview: Avery Dennison (AVY) Q2 Earnings Expected to Decline
Earnings Preview: Avery Dennison (AVY) Q2 Earnings Expected to Decline

The market expects Avery Dennison (AVY) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook

Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Philip Morris (PM) reports results for the quarter ended June 2025. While this widely-known consensus outlook is

Earnings Preview: General Motors (GM) Q2 Earnings Expected to Decline
Earnings Preview: General Motors (GM) Q2 Earnings Expected to Decline

General Motors (GM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a

Here's What Key Metrics Tell Us About Citigroup (C) Q2 Earnings
Here's What Key Metrics Tell Us About Citigroup (C) Q2 Earnings

For the quarter ended June 2025, Citigroup (C) reported revenue of $21.67 billion, up 7.6% over the same period last year. EPS came in at $1.96, compared to $1.52 in the year-ago quarter.

The

Best Momentum Stocks to Buy for July 15th
Best Momentum Stocks to Buy for July 15th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 15th:

Futu Holdings Limited FUTU: This online brokerage and wealth management platform

Growth ETFs Set New Records, Brush Off Tariff Headwinds
Growth ETFs Set New Records, Brush Off Tariff Headwinds

Wall Street has been showing huge resilience with the return of tariff threats. The Nasdaq Composite Index once again made a new record close, driven by the AI boom and confidence in corporate

Trade Tensions Hurting ZIM's Outlook: What's the Road Ahead?
Trade Tensions Hurting ZIM's Outlook: What's the Road Ahead?

ZIM Integrated Shipping ZIM, which had a stupendous 2024 courtesy of the Red Sea Shipping crisis-induced elevated freight rates, has been suffering this year mainly due to the tariff tensions.

The

Can Nebius Monetize Its Bets on ClickHouse, Avride and Toloka?
Can Nebius Monetize Its Bets on ClickHouse, Avride and Toloka?

Nebius Group N.V. NBIS is a Europe-based AI-infrastructure company. The stock price has seen a meteoric rise (up 146.4% in the past three months), outperforming the S&P 500’s 18.9% growth. NBIS is

Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect?

Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 5.5% over the past four weeks to close the last trading session at $34.71, but there could still be a solid upside left in the stock

Wall Street Analysts Believe Hillman Solutions Corp. (HLMN) Could Rally 40.8%: Here's is How to Trade
Wall Street Analysts Believe Hillman Solutions Corp. (HLMN) Could Rally 40.8%: Here's is How to Trade

Shares of Hillman Solutions Corp. (HLMN) have gained 13.1% over the past four weeks to close the last trading session at $7.77, but there could still be a solid upside left in the stock if

Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?
Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?

ARS Pharmaceuticals, Inc. (SPRY) closed the last trading session at $17.9, gaining 18.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Predict a 40.78% Upside in Navigator Holdings (NVGS): Here's  What You Should Know
Wall Street Analysts Predict a 40.78% Upside in Navigator Holdings (NVGS): Here's What You Should Know

Navigator Holdings (NVGS) closed the last trading session at $15.45, gaining 7.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect?
Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect?

Shares of LENZ Therapeutics, Inc. (LENZ) have gained 17% over the past four weeks to close the last trading session at $33.73, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet

Astrana Health, Inc. (ASTH) closed the last trading session at $25.12, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?
Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?

Shares of Rapt Therapeutics (RAPT) have gained 5.8% over the past four weeks to close the last trading session at $8.72, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet
Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet

Exact Sciences (EXAS) closed the last trading session at $54.3, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe TeraWulf (WULF) Could Rally 43.25%: Here's is How to Trade
Wall Street Analysts Believe TeraWulf (WULF) Could Rally 43.25%: Here's is How to Trade

Shares of TeraWulf Inc. (WULF) have gained 18% over the past four weeks to close the last trading session at $5.11, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Predict an 86.55% Upside in Zevra Therapeutics (ZVRA): Here's  What You Should Know
Wall Street Analysts Predict an 86.55% Upside in Zevra Therapeutics (ZVRA): Here's What You Should Know

Zevra Therapeutics (ZVRA) closed the last trading session at $12.79, gaining 40.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Artisan Partners Asset Management (APAM)'s Technical Outlook is Bright After Key Golden Cross
Artisan Partners Asset Management (APAM)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, Artisan Partners Asset Management Inc. (APAM) could be a good stock pick from a technical perspective. APAM recently experienced a "golden cross" event